Close Menu

NEW YORK – Myriad Genetics is partnering with the University of Leeds Center for Personalized Medicine and Health (LCPMH) to conduct a clinical utility study of the Prolaris prostate cancer test.

Prolaris analyzes the expression of 31 cell cycle genes, and may be combined with prostate specific antigen testing and Gleason score to gauge the aggressiveness of a patient's prostate cancer over the next decade.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Nov
14
Sponsored by
Qiagen

This webinar will discuss some of the issues laboratories face when transitioning to next-generation sequencing, and the key features to be considered for a successful implementation in routine testing.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.